US SB2665 | 2017-2018 | 115th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 12 2018 - 25% progression, died in committee
Action: 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 12 2018 - 25% progression, died in committee
Action: 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.
Title
A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.
Sponsors
Sen. Todd Young [R-IN] | Sen. Joe Donnelly [D-IN] |
History
Date | Chamber | Action |
---|---|---|
2018-04-12 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB2680 (Related) 2018-05-07 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 398.
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Government information and archives
Health
Health information and medical records
Medical ethics
Prescription drugs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Government information and archives
Health
Health information and medical records
Medical ethics
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/senate-bill/2665/all-info |
Text | https://www.congress.gov/115/bills/s2665/BILLS-115s2665is.pdf |